Cargando…
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Subclonal architecture and genomic evolution of small-cell lung cancer (SCLC) under treatment has not been well studied primarily due to lack of tumor specimens, particularly longitudinal samples acquired during treatment. SCLC is characterized by early hematogenous spread, which makes circulating c...
Autores principales: | Nong, Jingying, Gong, Yuhua, Guan, Yanfang, Yi, Xin, Yi, Yuting, Chang, Lianpeng, Yang, Ling, Lv, Jialin, Guo, Zhirong, Jia, Hongyan, Chu, Yuxing, Liu, Tao, Chen, Ming, Byers, Lauren, Roarty, Emily, Lam, Vincent K., Papadimitrakopoulou, Vassiliki A., Wistuba, Ignacio, Heymach, John V., Glisson, Bonnie, Liao, Zhongxing, Lee, J. Jack, Futreal, P. Andrew, Zhang, Shucai, Xia, Xuefeng, Zhang, Jianjun, Wang, Jinghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079068/ https://www.ncbi.nlm.nih.gov/pubmed/30082701 http://dx.doi.org/10.1038/s41467-018-05327-w |
Ejemplares similares
-
Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
por: Nong, Jingying, et al.
Publicado: (2019) -
Crizotinib versus platinum‐based double‐agent chemotherapy as the first line treatment in advanced anaplastic lymphoma kinase‐positive lung adenocarcinoma
por: Zhang, Quan, et al.
Publicado: (2015) -
HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib
por: Zhang, Xinyong, et al.
Publicado: (2020) -
Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
por: Zhang, Qi, et al.
Publicado: (2019) -
Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma
por: Qiao, Xiaojuan, et al.
Publicado: (2015)